Polyphenol Fingerprint, Biological Activities, and In Silico Studies of the Medicinal Plant Cistus parviflorus L. Extract Authors: Fatma A.A El-Shibani, Ghassan M. Sulaiman, Amr S. Abouzied, Amer Al Ali, Abdulnaser Kh Abdulkarim, Abdullah D. Alamami, Mohammed Asiri, Hamdoon A. Mohammed Published: 2023 ABSTRACT Cistus parviflorus L. (Cistaceae) is a medicinal plant with several folkloric applications, including being used for urinary tract infections and as a food additive. In this study, the polyphenolic diversity and the antioxidant, antidiabetic, and antimicrobial activities of the C. parviflorus methanolic extract were evaluated. Spectrophotometric and HPLC-based analyses using standard polyphenolic compounds were conducted to measure the phenolics and flavonoids in the plant extract. The in vitro DPPH, ORAC, FRAP, and α-glucosidase assays were used to evaluate the plant’s antioxidant and antidiabetic activities. Furthermore, disc diffusion and MIC-based microdilution tests were applied to evaluate the antimicrobial activity of the plant against broad-spectrum microorganisms. The analysis revealed the existence of high phenolic and flavonoid quantities that were measured at 302.59 ± 0.6 μg GAE and 134.3 ± 0.5 μg RE, respectively. The HPLC-based analysis revealed the existence of 18 phenolic acids and 8 flavonoids. The major phenolic acid was ellagic acid (169.03 ppm), while catechin was the major flavonoid (91.80 ppm). Remarkable antioxidant activity was measured using three different assays: DPPH, ORAC, and FRAP. Furthermore, strong inhibition of α-glucosidase compared to acarbose was recorded for the plant extract (IC50 0.924 ± 0.6). The results showed that C. parviflorus’s extract had a strong anti-Escherichia coli effect with MIC value of 0.98 μg\mL and IZD value of 32.2 ± 0.58 mm compared to 25.3 ± 0.18 mm for gentamycin, the positive control. Moreover, Aspergillus niger, Aspergillus fumigatus, Staphylococcus aureus, Streptococcus pyogenes, and Salmonella typhimurium all showed significant growth inhibition in response to the extract, a result that may be related to the use of the plant in traditional medicine to treat urinary tract infections. The docking study indicated the higher binding affinity of the major identified compounds, i.e., ellagic acid, rutin, naringin, catechin, and punicalagin, to the S. aureus gyrase-DNA complex, which might suggest the possible mechanisms of the plant as antimicrobial agents. Introduction Medicinal plants are a great global source of medications and have participated in the modern conventional medicinal system through their direct application in the treatment of various disorders, the use of their natural constituents in the treatment of diseases, or the use of these constituents as candidates for the new synthetic drug templates.1 The consequence of the contributions of natural product research to the modern medical system is that approximately 25% of the currently available drugs are nature-based or contain natural ingredients as part of the final medicinal product.2 There are regular demands for natural product-based drugs and natural supplements as alternatives to nonselective, more toxic, and less sensitive synthetic medicines.3 Plant-based natural products, such as drugs, have been part of the medical system for a long time.4 The drug development has followed the plants’ generated leads and culminated through the chemical profiling of the secondary metabolites present in the plants.5−7 In addition, the bioassay-guided chemical profiling of natural product constituents, as well as their biogenetic and biosynthetic interrelationships, provides input for SAR and QSAR. The process has provided ample structural inputs at the molecular and substructural levels to design and develop the pharmacophore, a prerequisite for new drug design and in silico testing. The experimental data on bioactivity obtained from bioassay-guided and random bioactivity testing of isolated-purified natural products has the potential to validate traditional herbal knowledge.8−10 The current research is investigating one of the medicinal plants that is used in traditional medicine in the Middle East and consumed as food in its growing areas. The plant is Cistus parviflorus. Cistus is a genus of flowering plants and one of the perennial shrubs in the Cistaceae family. This family is medium-sized, containing 180 species in 8 genera. Cistaceae is commonly named the Rock-Rose family and shows the highest diversity in the Mediterranean floristic region.11,12Cistus comprises about 30 species native to the Mediterranean area, represented by four species in Libya, among which C. parviflorus is known to be native in El-Jabal El-Akhdar, Libya.13,14 Previous research has reported the qualitative and quantitative analysis of compounds existing in different extracts of Cistus species. Furthermore, studies have evaluated their biological and pharmacological effects, which has been attributed to their healing properties. Colorimetric and high-performance liquid chromatography (HPLC) techniques were established as the most convenient methods to study and identify Cistus phytochemicals.15Cistus sp. species are a good source of natural antioxidant compounds, mostly flavonoids and polyphenols, that can capture toxic oxygen-free radicals and oxygen-reactive forms effectively. Oxidative stress components play an important role in providing and developing many ailments, including diabetes and Alzheimer’s disease.16 The activity of Cistus sp. as a reducing agent is due to its enhancement of the cellular defense mechanism and its aid in preventing oxidative damage to cellular components, which allows it to act either as a noncellular or cellularly powerful antioxidant agent.17 Furthermore, these compounds have been reported to have antimicrobial and antiinflammatory activity by blocking or suppressing COX1 and COX2.12 A phytochemical investigation showed that the leaves of C. parviflorus contain different classes of phenolic compounds. The isolated compounds were revealed as flavononols (kaempferol and quercetin derivatives), flavan 3-ol derivatives, hydroquinone, arbutin, methyl β-glucopyranoside, shikimic acid, and corchoionoside.16,18 Other study showed that punicalagin was identified in the studied plant, while myricetin glycosides and quercetin glycosides were comparatively low.19 C. parviflorus is a 100 cm-high shrub; its leaves are ovate-oblong in shape, and the plant flowers in March to May with light purple flowers.20 The plant is widely used in herbal medicine to treat a diverse range of conditions, including fevers and colds; digestive problems as well as diarrhea; and other inflammatory diseases such as skin diseases and rheumatism.20 Several flavonoids, including gallocatechin, quercetin, and kaempferol glycosides have been isolated from plant species growing in Turkey.16 Newly, epigallocatechin gallate, (+)-catechin, quercetin-3-O-rutinoside, quercetin, kaempferol-3-O-glucosides, and luteolin were identified in different amounts in hydroethanolic extracts of C. parviflorius, and strong antioxidant capacity was observed with the same extract.21 Also, 8-α-13-oxy-14-ene-epilabdane was one of the main components of the essential oil of C. parviflorus L. from Turkey.22 The chemical constituents and biological impacts of the Libyan C. parviflorus species have not yet been entirely determined. The plant, C. parviflorus, has been utilized in traditional medicine in the Al-Jabal Al Akhdar region as well as other areas of Libya for the treatment of urinary tract infections and gastritis.23 Given that growing environmental conditions have been considered crucial factors affecting the phytochemical and biological activities of medicinal plants, the main objective of the study was to analyze the phenolic and flavonoid constituents of C. parviflorus species growing in Libya using HPLC and spectrophotometric techniques. The antioxidant, antimicrobial, and antidiabetic activities of the plant extract were also measured using specific in vitro assays. The potential mechanisms of the plant’s antimicrobial effect were also studied using in silico computer-based analysis for the plausible binding affinities of the plant’s major constituents with specific targets. Materials and Methods Materials All of the solvents and reagents were of analytical grade. All of the flavonoids and phenolic acid standards were purchased from Sigma-Aldrich (Germany), and the purity was over 99.9%. The antioxidant reagents DPPH, TPTZ, and fluorescein were also obtained from Sigma-Aldrich (Germany). Plant Materials During April 2021, the aerial parts of the plant were gathered from Al-Jabal Al Akhdar, East Libya (Figure 1), and identified as C. parviflorus Lam. (Family Cistaceae) by the taxonomist at the Department of Botany, Faculty of Sciences, Benghazi University, Libya. The plant was air-dried, ground, and kept in tightly sealed, dark containers. A voucher specimen of the plant was housed in the herbarium of the Department of Botany, Faculty of Science, Benghazi University, with the number #DB-18876. Photograph of C. parviflorus L. herb from its native growing area in Al-Jabal Al Akhdar, Libya. Extract Preparation The plant has been extracted using a Soxhlet apparatus,24 where 100 g of powdered aerial parts of the plant were extracted with 70% methanol until exhaustion. To remove the remaining solvent, the extract was evaporated under a reduced-pressure vacuum, and the extractive yield was calculated as 3.57% of the dried plant powder. The dried extract materials were stored in a freezer at −20 °C for phytochemical measurements and biological evaluation. Quantitative Measurement of Phenolics and Flavonoids Total Phenolic Contents The Folin-Ciocalteu method was applied to determine the total phenolic content of the plant’s methanolic extract. The plant extract at a concentration of 1 mg/mL (1.6 mL), sodium carbonate solution (0.2 mL of 10% Na2CO3), and diluted Folin-Ciocalteu solution (0.2 mL) were mixed in a glass test tube and left for 30 min. The blue color intensity of the mixture was measured against a blank (distilled water) at 760 nm. The standard curve was created by using gallic acid. The analyses were conducted in triplicate and represented as mg gallic acid equivalents per gram dry weight of the extract (mg GAE/g).25 Total Flavonoid Contents The flavonoid contents of C. parviflorus methanolic extract were assessed using an aluminum chloride assay.26 The plant extract at a concentration of 1 mg/mL (1 mL) and AlCl3 solution (1 mL of 2% AlCl3) were mixed in a glass test tube and left for 15 min. The yellow color intensity of the mixture was measured against a blank (methanol) at 430 nm. The results were determined in triplicate and reported as milligrams of rutin equivalents per gram of the dry-weight plant extract. HPLC Analysis HPLC was used to determine flavonoid and phenolic components using the method described in the literature27 with modification. 0.5 g of the air-dried aerial portions of the plants, C. parviflorus, were blended with 40 mL of a 62.5% methanol–water mixture. The plant solvent mixture was centrifuged at 1000 rpm for 12 min. The mixture was filtered using a Milipore 0.2 m membrane, and the filtrate was diluted with methanol to a volume of 100 mL. Afterward, 1 mL of the filtrate was placed in a vial for injection into an HPLC system (Hewlett-Packard 1050) equipped with a lichrosorb RP 18 column (4.0 mm i.d., 250 mm; particle size 5m) (Merck, Dramastdt). Gradient separation was performed with a mobile phase of a methanol-acetonitrile mixture at a flow rate of 1 mL/min. Authentic phenolics and flavonoids were injected into HPLC after being dissolved in the mobile phase. Individual components were identified by comparing their retention times with those of authentic samples, which were equally tested. In Vitro Antioxidant Activity In Vitro 2,2-Diphenyl-1-picrylhydrazyl (DPPH) Scavenging Activity (DPPH-SA) The DPPH test was conducted using the method of Boly et al.,28 which was adjusted to fit the 96-well plates. In brief, 150 μL of freshly made DPPH reagent (constructed by dissolving 2 mg in 51 mL of HPLC-grade methanol) was added to 5 μL of the C. parviflorus extract (1 mg/mL) in a 96-well plate (n = 3). The mixture was kept in the dark at room temperature for 30 min. After the incubation time, a decline in DPPH color intensity at 517 nm was observed. To calculate the DPPH-SA to be comparable to Trolox, three separate measurements were used. Ferric Reducing Antioxidant Power (FRAP) Assay This approach depends on the capability of electron-donating antioxidants to convert a colorless ferric complex (Fe3+-tripyridyltriazine) to a blue-colored ferrous complex (Fe2+-tripyridyltriazine) at low pH. The change in absorbance at 593 nm is observed to monitor the reduction.29 The assay was conducted following the technique of Benzie et al.,30 with slight adjustments to suit microplates. In a 96-well plate, 190 μL of newly prepared TPTZ solution composed of acetate buffer (300 mM, PH = 3.6), TPTZ (10 mM in 40 mM HCl), and FeCl3 (20 mM), in a ratio of 10:1:1 v/v/v, respectively, was mixed with 10 μL of C. parviflorus extract (1 mg/mL). The reaction was left to sit at room temperature in the dark for 30 min. Using the created FRAP-Troplox calibration curve, the activity was determined as milligrams of Trolox equivalent per gram of the dried extract of the tested plant at 593 nm after the incubation procedure. Oxygen Radical Absorbance Capacity (ORAC) Assay The ORAC test relies on the capture of the peroxyl radicals produced by 2,2′-azobis (2-amidinopropane) dihydrochloride (AAPH), which inhibits the degradation of the fluorescein probe, thereby preventing the loss of fluorescence. The test was performed following the approach of Liang et al.,31 with adjustments. Briefly, 10 μL of the C. parviflorus extract (1 mg/mL) was left to incubate for 10 min at 37 °C with 30 μL of fluorescein (100 nM). Three cycles (cycle time, 90 s.) of fluorescence measurement (485 EX, 520 EM, nm) were performed for background measurement. Following that, each well received 70 μL of the freshly made AAPH (300 mM). The measurement of fluorescence (485 EX, 520 EM, nm) was carried out for 60 min (40 cycles, each 90 s). α-Glucosidase Inhibition Assay The α-glucosidase inhibitory colorimetric assay was conducted using Bio Vision’s kit (K938-100, 70 kDa lysosomal α-glucosidase (EC:3.2.1.20)) as per the literature.32 In brief, the enzyme α-glucosidase (0.1 U/mL) and substrate p-nitrophenyl-d-glucopyranoside (p-NPG, 1 mM) were mixed together in potassium phosphate buffer (0.1M, pH 6.7). The C. parviflorus extract was subsequently diluted in DMSO at concentrations ranging from 0.1 to 50 mg/mL. The enzyme (20 μL) was incubated with 120 μL of the different concentrations of the plant extract in a 96-well flat-bottom microplate at 37 °C for 10 min, and then a substrate (20 μL) was added to the mixture to allow the enzymatic reaction to continue for 30 min. To halt the reaction, 80 μL of Na2CO3 (0.2 M) was added; the absorbance was measured at 405 nm. To calculate the IC50 values, the samples were examined in duplicate. As a reference agent, acarbose was employed, and the results were presented as a percentage inhibition. Antimicrobial Activity Microorganisms The microorganisms were provided by the Al-Azhar Regional Center for Mycology and Biotechnology, Al-Azhar University, in Cairo. The fungal strains Aspergillus fumigatus (RCMB02564), Aspergillus niger (RCMB02542), Candida albicans (RCMB05035), and Candida tropicalis (RCMB 05084); the Gram-positive bacteria, Staphylococcus aureus (RCMB010027), Staphylococcus epidermidis (RCMB010024), Streptococcus pyogenes (RCBM010015), and Bacillus subtilis (RCBM010067); and the Gram-negative bacteria, Porteous vulgaris (RCMB 010085), Pseudomonas aeruginosa (RCMB 010043), Salmonella typhimurium (RCMB010315), and Escherichia coli (RCMB010056) were utilized in the antimicrobial assays. Disc Diffusion Assay The disc diffusion method was used to test the antibacterial activity. The surface of the agar plates that have been evenly streaked with the microbial pathogen was covered with a number of paper discs containing different standard antibiotics and tested methanolic plant extracts. 50 μL of the plant extract at 100 mg/mL was placed on the disks. The same amount of DMSO (1% v/v) was utilized as a blank, while discs (50 mg/disc) containing ampicillin, gentamycin, and amphotericin β were utilized as standard antibiotics against Gram-positive bacteria, Gram-negative bacteria, and fungal strains, respectively. For bacterial strains, the bacteria were subcultured on brain-heart infusion agar. The agar was streaked with the organisms’ respective broth cultures (0.5 McFarland solution, which corresponded to the microbial concentration of 108 CFU/mL33), and left for 15 min for the absorption to occur. For fungal strains, discs were placed in sabouraud dextrose agar. The plates were observed after an overnight incubation at 37 °C in the case of an antibacterial test and for 2 days after incubation at 25 °C in the case of an antifungal assay to detect the development of zones of inhibition around the edges of the disc. The diameters of the inhibition zones were measured in millimeters, and the data were expressed as the mean ± SD of three independent experiments.34 Broth Microdilution Method The procedure for determining the minimum inhibitory concentration (MIC) involved a serial dilution technique based on the literature method.26 The plant extract was dissolved in DMSO (5% v/v) at a concentration of 10 mg/mL, and serially diluted with Muller Hinton Broth (MHB) in a 96-well plate using a calibrated micropipet (100 μL of the extract to 100 μL of the MHB). To each well, 100 μL of the microbial suspensions were added (5.0 × 105 CFU/mL). Negative and positive controls were performed. The validity of the test was confirmed after the microtiter plates had been incubated for 48 h at 28 °C for fungi and 24 h at 37 °C for bacteria. The plates were then taken out of the incubator and placed in the dark to check for microbial growth; the turbidity of the solution was a sign of the microbial growth. Docking Study In order to investigate how phenolic acids and flavonoid chemicals function as inhibitors for the S. aureus gyrase-DNA complex, docking experiments were carried out using a software suite.35 In the evaluation, these compounds’ binding scores and modes were evaluated using RXV. ChemOffice PerkinElmer Suite 2017 was used and followed a typical process to prepare the compounds for docking.36 The cocrystallized inhibitor (RXV) and the screened compounds were both entered into a database and saved as an MDB file. The S. aureus gyrase-DNA complex’s X-ray structure was taken from the Protein Data Bank (PDB entry: 2XCS)37 and prepared in a number of ways, including error correction, the insertion of 3D hydrogens, and energy minimization.38 The active site file was loaded to start the docking process. Triangle matcher was used as the placement strategy, ligand atoms as the docking procedure site, and London dG as the scoring method. The top 10 postures for each drug were chosen from a pool of 30 poses produced via stiff receptor docking. Further examination of the chosen poses was conducted with an emphasis on those displaying the highest scores, RMSD values ≤2, and beneficial interactions between phytochemical screened compounds and targeted proteins. Using the cocrystallized ligand (RXV) in the constructed target protein’s binding pocket, a redocking step was carried out to verify the accuracy of the docking software.39 The results were visualized using Discovery Studio 4.0 software. Statistical Analysis The results of each group are stated as the mean along with their standard deviations. One-way ANOVA was carried out to assess statistically significant changes. Results and Discussion Phytochemical Contents of C. parviflorus Extract The current work reports for the first time the phytochemical constituents and bioactivities of C. parviflorus species growing in Libya. The results shown in Table 1 indicated the presence of high amounts of the phenolic acids and flavonoids, which were measured at 302.59 and 134.3 mg, respectively, as equivalents to gallic acid and rutin per gram of the dried methanolic extract. The quantities of phenolic acids and flavonoids in C. parviflorus grown in different areas have been reported. For example, the plant species growing in Crete (Greek Island) have been examined for their total phenolic contents and antioxidant activity. The results indicate the presence of 351.2 ± 19.3 mg GAE/g of the phenolic acids, which inhibited the DPPH color at an IC50 value of 18.5 ± 0.6 g/mL.40 The plant has shown much higher contents of phenolic acids and flavonoids as compared with other Cistus species, i.e., Cistus creticu, that exhibited total phenolic and flavonoids ranging from 43.81 to 132.99 mg GAE/g and 2.45–10.93 mg quercetin/g, respectively. Also, C. salviifolius growing in Spain has shown phenolic contents of 60.1 g GAE/100 g of the plant extract.41 Furthermore, three Cistus species growing in Tunisia, i.e., C. monspeliensis, C. libanotis, and C. villosus, have demonstrated much lower levels of the phenolic acids (33.16, 32.51, and 40.51 mg GAE/g, respectively) and flavonoid contents (5.59, 9.44, and 8.49 mg epicatechin/g), compared to the current results for the total phenolics and flavonoids of C. parviflorus (Table 1).42 Similarly, lower levels of the phenolic and flavonoid contents have also been reported in the C. criticus and C. salvifolius extracts from the plant species growing in Syria.12 Table 1Total Phenols and Flavonoid Contents of the C. parviflorus Methanolic Extractsamplephenolic (mg GA/g)aflavonoids (mg Rut/g)bextractive yield (%)C. parviflorus302.59 ± 0.6134.3 ± 0.53.57aGallic acid (GA) equivalent.bRutin (Rut) equivalent. Total Phenols and Flavonoid Contents of the C. parviflorus Methanolic Extract Gallic acid (GA) equivalent. Rutin (Rut) equivalent. The HPLC analysis of the C. parviflorus methanolic extract has been conducted using standard phenolic acids and flavonoids to confirm the presence of 17 phenolic acids, eight flavonoids, and one ellagitannin in the plant extract. The ellagitannin compound punicalagin was estimated at 13.63; however, the identified phenolic acids and flavonoid quantities were 550.03 and 167.73 ppm, respectively. Among all the phenolic acids and flavonoids, ellagic acid and catechin were the most abundant compounds in the plant, with their contents at 169.03 and 91.80 ppm, respectively (Table 2). Furthermore, several phenolic acids were detected at relatively higher concentrations, such as protocatechuic acid, 3-OH-tyrosol, and catechol, which were found at concentrations of 91.39, 74.25, and 54.11 ppm, respectively. Also, rutin and naringin flavonoid glycosides were detected at relatively higher concentrations (32.50 and 21.12 ppm, respectively) compared to other identified flavonoids. The two main flavonoids detected by HPLC in the C. parviflorus extract were flavan-3-ol (catechin) and flavonol-based (rutin) flavonoids, which were measured at values of 91.80 and 32.50 ppm, respectively. The plant C. parviflorus is native to Turkey, Greece, and Libya. The plant species C. parviflorus, along with the other four species of the genus Cistus growing in Turkey, have been recently investigated by Onal et al. using HPLC for the presence of flavonoids. The results indicated the absence of rutin (quercetin-3-rutinoside) in C. parviflorus and C. salviifolius; however, rutin has been detected in all other species, i.e., C. criticus, C. laurifolius, and C. monspeliensis. In addition, they have detected kaempferol-3-glucoside only in C. criticus.21 The analysis also revealed the presence of epigallocatechin gallate, luteolin, quercetin-3-glucoside, and catechin in the extract of C. parviflorus at concentrations of 5.78, 15.21, 0.84, and 5.35, respectively.21 The findings of the study by Onal et al. demonstrated the plant’s biogenetic capacity to synthesize various flavonoids and demonstrated that C. parviflorus, a species native to Libya, is capable of producing more flavonoids than plant species found in Turkey. Furthermore, phenolic acids, flavonoids, and ellagitannin have been detected in several European Cistus species and appear to be the predominant compounds of the species. In that context, different isomers of punicalagin and several quercetin glycosides have been identified in C. criticus growing in Europe. Also, flavonoids, catechin derivatives, and phenolic acids have been identified in Cistus salvifolius and Cistus ladanifer.43,44 Table 2HPLC-Based Phenolic Acid and Flavonoid Identification in the C. parviflorus Aerial PartnoR.tpolyphenolscontents (ppm)14.501gallic acid4.3028.150ellagic acid169.0338.200kaempferol0.948.3263-OH-tyrosol74.2558.873apigenin0.669.045protocatechuic acid91.3979.469catechol54.1189.780quercetin5.16910.238chlorogenic acid27.201011.229p-coumaric acid42.141111.309hesperetin3.21211.573naringin21.121311.811rutin32.501411.932cinnamic acid24.351512.485catechin91.801612.892quercetrin12.451713.279punicalagin13.631814.5744-hydoxybenzoic acid14.821915.198caffeic acid12.252016.034vanillic acid5.532116.860ferulic acid1.552217.845rosmarinic acid2.912320.017pyrogallol7.362420.456benzoic acid4.582521.6353,4,5-trimethoxy cinnamic acid1.342623.389salicylic acid3.72phenolics550.03flavonoids167.73total717.76 HPLC-Based Phenolic Acid and Flavonoid Identification in the C. parviflorus Aerial Part Antioxidant Activity of C. parviflorus In the literature, phenolic acids and flavonoids have been shown to have antioxidant properties.45 Additionally, the health advantages of these categories of natural products on many human body systems, such as the cardiovascular, hepatic, renal, and central neurological systems, are also proven and linked to their antioxidant activity.45,46 Owing to the presence of phenolic acids and flavonoids in the Cistus species, several reports have investigated the antioxidant activity of these plants and proven their potential health benefits.17,19,42,47−50 In the current report, the antioxidant activity as well as other activities, i.e., antidiabetic and antimicrobial activities, are demonstrated for the first time for C. parviflorus growing in Libya. Three different in vitro methods were conducted and gave information on the free radical scavenging activity of the plant, i.e., DPPH; the ability of the plant constituents to capture the peroxyl radicals, i.e., ORAC; and the ferric reducing capability of the plant constituents, i.e., FRAP. We have a plan to measure the in vivo antioxidant activity of the plant’s pure constituents in our coming research. The measured antioxidant activity in Table 3 indicated the reducing ability of the plant extract, indicated by the FRAP value of 27.10 μmol Trolox/mg, and its ability to capture free radicals, indicated by the reduction of DPPH color (4.65 μmol Trolox/mg) and the ORAC value of 13.32 μmol Trolox/mg. These results are consistent with the phytochemical investigation results that revealed the presence of several phenolic acids and flavonoids in the plant extract (Table 3). The results are also consistent with the reported results of the antioxidant activity of C. parviflorus growing on the Greek island of Crete, as the plant showed a DPPH radical scavenging effect at an IC50 value below 50 μg/mL.40 The current results are also comparatively similar to the reported results for C. parviflorus and other species of Cistus growing in Turkey.51 Table 3In Vitro Antioxidant Activity of C. parviflorus Methanolic ExtractassaysDPPH (μmol Trolox/mg)FRAP (μmol Trolox/mg)ORAC (μmol Trolox/mg)C.parviflorus4.65 ± 1.1527.10 ± 0.9413.32 ± 2.26 In Vitro Antioxidant Activity of C. parviflorus Methanolic Extract Anti-α-Glucosidase Activity of C. parviflorus The current study also investigated the anti-α-glucosidase activity of the plant methanolic extract as an indicator for the antidiabetic effect of the plant. The results displayed in Table 4 indicate the ability of the plant extract to inhibit α-glucosidase (IC50 value at 0.954 ± 0.2) at a relatively similar level as the standard antidiabetic drug, i.e., acarbose (IC50 value at 0.789 ± 0.012). The α-glucosidase inhibitory effect of C. parviflorus and other species of Cistus growing in Turkey has been reported and revealed the potential antidiabetic effect of the Cistus species through their ability to inhibit the diabetic-related enzymes, e.g., α-glucosidase, α-amylase, and advanced-glycation end products.51 The current finding of the α-glucosidase activity of the plant can be attributed to the presence of phenolic acids and flavonoids in the plant extract, as have been reported for such classes of natural products.52,53 Table 4α-Glucosidase Inhibitory Effects of the Aerial Parts of C. parviflorussampleIC50 (mg/mL)C. parviflorus0.954 ± 0.2acarbose0.789 ± 0.012 α-Glucosidase Inhibitory Effects of the Aerial Parts of C. parviflorus Antimicrobial Activity of C. parviflorus The plant, C. parviflorus, is traditionally used in Libya for the treatment of urinary tract infections, as reported in the literature.23 Therefore, the antimicrobial testing of the plant extract was one of the biological screening targets in the current work. The disc diffusion and the serial dilution assays were used to observe the inhibition zone diameter and the MIC induced by the plant extract against several microbial pathogens of the fungal, Gram-positive, and Gram-negative strains. The results shown in Table 5 revealed the broad-spectrum antimicrobial activity of the plant extract, as indicated by its ability to induce substantial inhibition zones and MIC values against all fungal strains except C. albicans; all Gram-positive stains except S. epidermidis; and against S. Typhimurium and E. coli Gram-negative bacteria (Table 5). The results displayed in Table 5 also indicated the strong antibacterial activity of the plant extract against E. coli (IZD value of 32.2 ± 0.58 mm and MIC value of 0.98 μg\mL) as compared to the positive control, gentamycin (IZD value of 25.3 ± 0.18 mm). The use of the plant in traditional medicine for the treatment of urinary tract infections could be attributed to its inhibitory effect on E. coli, the pathogen that is well-known and considered a primary cause of urinary tract infections.54 The results in Table 5 also indicated that C. parviflorus ethanol extract has substantial activity against A. niger (IZD value of 19.4 ± 0.72 mm and MIC value of 3.9 μg\mL)and A. fumigatus (IZD value of 18.6 ± 1.2 mm and MIC value of 3.9 μg\mL) as compared to the antifungal standard compound, amphotericin B, which showed IZDs equal to 21.9 ± 0.58 mm and 23.7 ± 0.63 mm and MIC values of 0.98 μg\mL and 0.49 μg\mL, against both fungal strains, respectively. In addition, moderate IZD and higher MIC values equal to 15.2 ± 0.63 mm and 32.5 μg\mL were recorded for the plant extract against C. tropicalis as compared to amphotericin B (IZD value of 25.4 ± 1.5 mm and MIC value of 0.49 μg\mL). The results also indicated substantial antibacterial activity of the plant extract against all Gram-positive and Gram-negative tested bacterial strains compared to the positive controls, except for S. epidermidis, P. vulgaris, and P. aeruginosa. Previous reports have investigated the antimicrobial effect of the plant C. parviflorus growing in Turkey and revealed some effectiveness against B. cereus and B. subtilis.55 The presence of phenolic acids, flavonoids, and ellagitannins in C. parviflorus may be responsible for its antibacterial effect. For example, the ellagitannin punicalagin has been reported to have antioxidant, anticancer, hepatoprotective, antiviral, antibacterial, neuroprotective, gastroprotective, antiinflammation, pre-eclampsia, antihyperlipidemic, and antidiabetic properties.56 In addition, benzoic acid, cinnamic acid, and p-coumaric acid have also been reported for their antimicrobial effects.57−59 Table 5Antimicrobial Activity of the Aerial Parts of the C. parviflorus Measured as the Diameter of the Zone of Inhibition in mm*microorganismssampleszone of inhibition mm (mean ± S.D)C. parviflorus extractMIC (μg\mL)standardMIC (μg\mL)fungi amphotericin B Aspergillus fumigatus (RCMB02564)18.6 ± 1.23.923.7 ± 0.630.49Aspergillus niger (RCMB02542)19.4 ± 0.723.921.9 ± 0.580.98Candida albicans (RCMB05035)NA 26.4 ± 0.720.49Candida tropicalis (RCMB 05084)15.2 ± 0.6332.525.4 ± 1.50.49Gram-positive bacteria ampicillin Staphylococcus aureus (RCMB010027)21.3 ± 1.21.9528.9 ± 1.20.24Staphylococcus epidermidis (RCMB010024)NA 25.4 ± 0.630.49Streptococcus pyogenes (RCBM010015)22.4 ± 0.580.9826.4 ± 0.340.49Bacillus subtilis (RCBM010067)26.34 ± 0.630.4932.4 ± 1.20.24Gram-negative bacteria gentamycin Porteous vulgaris (RCMB 010085)NA 23.4 ± 0.580.49Pseudomonas aeruginosa (RCMB 010043)NA 17.3 ± 0.6315.63Salmonella typhimurium (RCMB010315)21.4 ± 1.21.9524.8 ± 0.630.49Escherichia coli (RCMB010056)32.2 ± 0.580.9825.3 ± 0.180.49 Antimicrobial Activity of the Aerial Parts of the C. parviflorus Measured as the Diameter of the Zone of Inhibition in mm* S. aureus Gyrase-DNA Complex Binding Affinity of the Major Identified Compounds S. aureus gyrase, also referred to as DNA gyrase, is an enzyme present in the bacterium S. aureus.39 This enzyme belongs to the category of type II topoisomerases and plays a pivotal role in DNA replication and the maintenance of DNA supercoiling. Its primary function involves introducing negative supercoils into bacterial DNA to alleviate torsional stress during DNA replication and transcription processes.60,61 To investigate the binding modes of potential antimicrobial candidates containing phenolic and flavonoid compounds against the target enzyme within the S. aureus gyrase-DNA complex, molecular docking was conducted. S. aureus gyrase serves as a target for antibacterial drugs due to the disruption it can cause in bacterial DNA replication, ultimately leading to cell death. A lower binding energy resulting from the interaction between phenolic and flavonoid compounds and the targeted enzyme indicates higher binding efficiency compared to the native cocrystallized ligand (RXV), which serves as a reference control (demonstrating a binding energy of −8.9), as depicted in Table 6. Details of the binding scores and specific binding interactions, along with their corresponding bond types, are presented in Table 6. Table 6Affinity Scores, Amino Acid Connections, and RMSD Values of the Phenolic, Flavonoid Contents and Co-Crystallized Inhibitor (RXV) with the Target Enzyme of the S. aureus Gyrase-DNA Complexcompoundsaffinity scores (kcal/mol)RMSD(Å)amino acid connectedbond length (Å)kind of bondingellagic acid–9.31.21chain B:2.66pi-cationLYS4442.88hydrogen bondARG4473.55van der WaalsASP4483.93pi-alkylSER449 pi-cationchain D: PHE10973.84van der WaalsSER11123.11van der WaalsMET11133.34hydrogen bondASP11142.64, 2.49hydrogen bondLEU12982.91hydrogen bondARG12993.22van der Waals3-OH-tyrosol–61.53chain B: van der WaalsLYS4442.21van der WaalsARG4473.99van der WaalsASP4483.74van der WaalsSER4493.68 chain D: hydrogen bondLYS12702.87hydrogen bondTHR12962.88hydrogen bondASP11142.24, 2.97hydrogen bondprotocatechuic acid–6.31.67chain B: pi-sigmaARG11372.89van der WaalsLEU11333.10donor-donorASN10543.93hydrogen bondASP11383.47, 3.22hydrogen bondrutin–10.11.11chain B: PRO11022.79pi-alkylASP10963.01pi-anionASP11052.98hydrogen bondARG14852.91hydrogen bondPHE14802.28hydrogen bondnaringin–111.13chain B: ASP11142.95pi-cationLYS12702.91pi-anionALA10542.44hydrogen bondASN11092.76hydrogen bondGLY11082.58hydrogen bondGLY11062.49donor-donorchain D: ARG4473.83hydrogen bondASN5872.90hydrogen bondSER4422.66hydrogen bondSER4452.81 catechin–91.15chain B: ARG10923.11van der WaalsSER10983.96donor-donorGLN10952.24hydrogen bondASP11162.45hydrogen bondGLN12672.56hydrogen bondVAL12683.11hydrogen bondpunicalagin–11.61.12chain B: THR11893.23pi-alkylARG14773.92van der WaalsLYS11302.33hydrogen bondGLY14812.65hydrogen bondRXV–8.90.47chain B: ALA11803.71pi-alkylLYS4443.75van der Waalschain D:2.92hydrogen bondGLY11742.88, 2.84hydrogen bondGLN1267 hydrogen bond Affinity Scores, Amino Acid Connections, and RMSD Values of the Phenolic, Flavonoid Contents and Co-Crystallized Inhibitor (RXV) with the Target Enzyme of the S. aureus Gyrase-DNA Complex With energy scores of −9.3, −10.1, −11, −9, and −11.6 kcal/mol, respectively, ellagic acid, rutin, naringin, catechin, and punicalagin demonstrated superior binding scores in comparison to the cocrystallized inhibitor with the S. aureus gyrase-DNA complex. Notably, naringin formed seven hydrogen bonds with the amino acids SER445, ASN1109, SER442, GLY1108, ASN587, GLY1106, and ALA1094 at distances ranging from 2.44 to 2.90 Å, demonstrating the most favorable binding interactions with the S. aureus gyrase-DNA complex. Ellagic acid also connected with the receptor, forming four hydrogen bonds at distances ranging from 2.49 to 2.91 Å with the amino acids ARG447, LEU1298, and ASP1114. This interaction is shown in Figure 2. Numerous hydrogen and hydrophobic interactions were found during the in silico screening of enzyme-targeted phenolic and flavonoid constituents of C. parviflorus (Table 6). As shown in Table 6 and Figure 2, these phytochemical components had binding energies that ranged from ΔG −6 to −11.6 kcal/mol, suggesting the possibility of interactions with the active sites in the S. aureus gyrase-DNA complex (Supporting Information, Figures S2–S9). Interactions between (A) naringin and (B) punicalagin with the active site residues of the S. aureus gyrase-DNA complex in 3D and 2D. Conclusions This study contains phytochemical and biological evaluations for C. parviflorus as the first report for the plant species growing in Libya. The study results indicated that this plant has several polyphenolic constituents and high amounts of phenolic acids and flavonoids, which, in part, participated in the biological activities and traditional applications of the plant. The methanolic extract of C. parviflorus had substantial antimicrobial properties, especially against E. coli, which might be connected to the application of the plant in traditional medicine for the treatment of urinary tract infections. Furthermore, our findings suggested that the plant has considerable in vitro antioxidant and α-glucosidase potential, which is attributed to the presence of various phenolic acids and flavonoids in the plant extract. The study also recorded higher binding affinity of the major identified compounds of the plant to the S. aureus gyrase-DNA complex, which might suggest the possible mechanisms of the plant’s antimicrobial effect. As a result, this plant may be a source of effective medicinal compounds that can be employed as a natural preservative in pharmaceutical, cosmeceutical, and food applications. Additional studies on a wide range of bacteria and fungi are required to assess the spectrum of such plant extracts. Furthermore, different components of the investigated plants must be evaluated for their actions.